Literature DB >> 29678287

Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk.

András D Tóth1, Gábor Turu2, László Hunyady3, András Balla2.   

Abstract

AT1 angiotensin receptor (AT1R), a prototypical G protein-coupled receptor (GPCR), is the main receptor, which mediates the effects of the renin-angiotensin system (RAS). AT1R plays a crucial role in the regulation of blood pressure and salt-water homeostasis, and in the development of pathological conditions, such as hypertension, heart failure, cardiovascular remodeling, renal fibrosis, inflammation, and metabolic disorders. Stimulation of AT1R leads to pleiotropic signal transduction pathways generating arrays of complex cellular responses. Growing amount of evidence shows that AT1R is a versatile GPCR, which has multiple unique faces with distinct conformations and signaling properties providing new opportunities for functionally selective pharmacological targeting of the receptor. Biased ligands of AT1R have been developed to selectively activate the β-arrestin pathway, which may have therapeutic benefits compared to the conventional angiotensin converting enzyme inhibitors and angiotensin receptor blockers. In this review, we provide a summary about the most recent findings and novel aspects of the AT1R function, signaling, regulation, dimerization or oligomerization and its cross-talk with other receptors, including epidermal growth factor (EGF) receptor, adrenergic receptors and CB1 cannabinoid receptor. Better understanding of the mechanisms and structural aspects of AT1R activation and cross-talk can lead to the development of novel type of drugs for the treatment of cardiovascular and other diseases.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  GPCR; angiotensin II; bias; dimerization; receptor cross-talk

Mesh:

Substances:

Year:  2018        PMID: 29678287     DOI: 10.1016/j.beem.2018.02.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  10 in total

Review 1.  Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review.

Authors:  Ahmed Rakib; Taslima Akter Eva; Saad Ahmed Sami; Saikat Mitra; Iqbal Hossain Nafiz; Ayan Das; Abu Montakim Tareq; Firzan Nainu; Kuldeep Dhama; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

Review 2.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

3.  Administration of losartan preserves cardiomyocyte size and prevents myocardial dysfunction in tail-suspended mice by inhibiting p47phox phosphorylation, NADPH oxidase activation and MuRF1 expression.

Authors:  Liwen Liang; Wenyi Yuan; Lina Qu; Huili Li; Lulu Zhang; Guo-Chang Fan; Tianqing Peng
Journal:  J Transl Med       Date:  2019-08-22       Impact factor: 5.531

4.  Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7.

Authors:  Amanat Ali; Abdulrasheed Palakkott; Arshida Ashraf; Isra Al Zamel; Bincy Baby; Ranjit Vijayan; Mohammed Akli Ayoub
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

5.  Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor.

Authors:  Viktória B Horváth; Eszter Soltész-Katona; Éva Wisniewski; Anikó Rajki; Eszter Halász; Balázs Enyedi; László Hunyady; András Dávid Tóth; Gergő Szanda
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

6.  GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo.

Authors:  Celina M Pollard; Jennifer Ghandour; Natalie Cora; Arianna Perez; Barbara M Parker; Victoria L Desimine; Shelby L Wertz; Janelle M Pereyra; Krysten E Ferraino; Jainika J Patel; Anastasios Lymperopoulos
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

7.  Influence of Angiotensin II on cell viability and apoptosis in rat renal proximal tubular epithelial cells in in vitro studies.

Authors:  Aleksandra Piotrowska; Magdalena Chmielewska; Waldemar Andrzejewski; Piotr Dziegiel; Marzenna Podhorska-Okolow
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Jul-Sep       Impact factor: 1.636

Review 8.  Neurocardiac regulation: from cardiac mechanisms to novel therapeutic approaches.

Authors:  E N Bardsley; D J Paterson
Journal:  J Physiol       Date:  2018-11-12       Impact factor: 5.182

Review 9.  Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases.

Authors:  Dhanush Haspula; Michelle A Clark
Journal:  Int J Mol Sci       Date:  2020-10-17       Impact factor: 5.923

10.  Characterization of Type 1 Angiotensin II Receptor Activation Induced Dual-Specificity MAPK Phosphatase Gene Expression Changes in Rat Vascular Smooth Muscle Cells.

Authors:  Janka Borbála Gém; Kinga Bernadett Kovács; Laura Szalai; Gyöngyi Szakadáti; Edit Porkoláb; Bence Szalai; Gábor Turu; András Dávid Tóth; Mária Szekeres; László Hunyady; András Balla
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.